rs758974396

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2

The NM_000719.7(CACNA1C):​c.6064G>C​(p.Ala2022Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000015 in 1,601,444 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.000033 ( 0 hom., cov: 33)
Exomes š‘“: 0.000013 ( 1 hom. )

Consequence

CACNA1C
NM_000719.7 missense

Scores

1
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: 0.418

Publications

3 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
ITFG2-AS1 (HGNC:53128): (ITFG2 antisense RNA 1)
CACNA1C-AS1 (HGNC:40119): (CACNA1C antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.085822344).
BP6
Variant 12-2688726-G-C is Benign according to our data. Variant chr12-2688726-G-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 411732.
BS2
High AC in GnomAd4 at 5 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1CNM_000719.7 linkc.6064G>C p.Ala2022Pro missense_variant Exon 46 of 47 ENST00000399655.6 NP_000710.5 Q13936-12
CACNA1CNM_001167623.2 linkc.6064G>C p.Ala2022Pro missense_variant Exon 46 of 47 ENST00000399603.6 NP_001161095.1 Q13936-37

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1CENST00000399603.6 linkc.6064G>C p.Ala2022Pro missense_variant Exon 46 of 47 5 NM_001167623.2 ENSP00000382512.1 Q13936-37
CACNA1CENST00000399655.6 linkc.6064G>C p.Ala2022Pro missense_variant Exon 46 of 47 1 NM_000719.7 ENSP00000382563.1 Q13936-12
CACNA1CENST00000682544.1 linkc.6403G>C p.Ala2135Pro missense_variant Exon 49 of 50 ENSP00000507184.1 A0A804HIR0
CACNA1CENST00000406454.8 linkc.6277G>C p.Ala2093Pro missense_variant Exon 47 of 48 5 ENSP00000385896.3 F5GY28
CACNA1CENST00000399634.6 linkc.6244G>C p.Ala2082Pro missense_variant Exon 46 of 47 5 ENSP00000382542.2 E9PDI6
CACNA1CENST00000683824.1 linkc.6229G>C p.Ala2077Pro missense_variant Exon 47 of 48 ENSP00000507867.1 A0A804HKC4
CACNA1CENST00000347598.9 linkc.6208G>C p.Ala2070Pro missense_variant Exon 48 of 49 1 ENSP00000266376.6 Q13936-11
CACNA1CENST00000344100.7 linkc.6187G>C p.Ala2063Pro missense_variant Exon 46 of 47 1 ENSP00000341092.3 Q13936-14
CACNA1CENST00000327702.12 linkc.6169G>C p.Ala2057Pro missense_variant Exon 47 of 48 1 ENSP00000329877.7 A0A0A0MR67
CACNA1CENST00000399617.6 linkc.6169G>C p.Ala2057Pro missense_variant Exon 47 of 48 5 ENSP00000382526.1 A0A0A0MSA1
CACNA1CENST00000682462.1 linkc.6154G>C p.Ala2052Pro missense_variant Exon 46 of 47 ENSP00000507105.1 A0A804HIJ8
CACNA1CENST00000683781.1 linkc.6154G>C p.Ala2052Pro missense_variant Exon 46 of 47 ENSP00000507434.1 A0A804HJB6
CACNA1CENST00000683840.1 linkc.6154G>C p.Ala2052Pro missense_variant Exon 46 of 47 ENSP00000507612.1 A0A804HJR1
CACNA1CENST00000683956.1 linkc.6154G>C p.Ala2052Pro missense_variant Exon 46 of 47 ENSP00000506882.1 A0A804HI37
CACNA1CENST00000399638.5 linkc.6148G>C p.Ala2050Pro missense_variant Exon 47 of 48 1 ENSP00000382547.1 Q13936-31
CACNA1CENST00000335762.10 linkc.6139G>C p.Ala2047Pro missense_variant Exon 47 of 48 5 ENSP00000336982.5 F5H522
CACNA1CENST00000399606.5 linkc.6124G>C p.Ala2042Pro missense_variant Exon 47 of 48 1 ENSP00000382515.1 Q13936-30
CACNA1CENST00000399621.5 linkc.6121G>C p.Ala2041Pro missense_variant Exon 46 of 47 1 ENSP00000382530.1 Q13936-24
CACNA1CENST00000399637.5 linkc.6121G>C p.Ala2041Pro missense_variant Exon 46 of 47 1 ENSP00000382546.1 Q13936-27
CACNA1CENST00000402845.7 linkc.6121G>C p.Ala2041Pro missense_variant Exon 46 of 47 1 ENSP00000385724.3 Q13936-13
CACNA1CENST00000399629.5 linkc.6115G>C p.Ala2039Pro missense_variant Exon 46 of 47 1 ENSP00000382537.1 Q13936-32
CACNA1CENST00000682336.1 linkc.6106G>C p.Ala2036Pro missense_variant Exon 46 of 47 ENSP00000507898.1 A0A804HKE9
CACNA1CENST00000399591.5 linkc.6088G>C p.Ala2030Pro missense_variant Exon 45 of 46 1 ENSP00000382500.1 Q13936-29
CACNA1CENST00000399595.5 linkc.6088G>C p.Ala2030Pro missense_variant Exon 45 of 46 1 ENSP00000382504.1 Q13936-25
CACNA1CENST00000399649.5 linkc.6082G>C p.Ala2028Pro missense_variant Exon 45 of 46 1 ENSP00000382557.1 Q13936-15
CACNA1CENST00000399597.5 linkc.6064G>C p.Ala2022Pro missense_variant Exon 46 of 47 1 ENSP00000382506.1 Q13936-22
CACNA1CENST00000399601.5 linkc.6064G>C p.Ala2022Pro missense_variant Exon 46 of 47 1 ENSP00000382510.1 Q13936-20
CACNA1CENST00000399641.6 linkc.6064G>C p.Ala2022Pro missense_variant Exon 46 of 47 1 ENSP00000382549.1 Q13936-23
CACNA1CENST00000399644.5 linkc.6064G>C p.Ala2022Pro missense_variant Exon 46 of 47 1 ENSP00000382552.1 Q13936-21
CACNA1CENST00000682835.1 linkc.6064G>C p.Ala2022Pro missense_variant Exon 46 of 47 ENSP00000507282.1 A0A804HIZ0
CACNA1CENST00000683482.1 linkc.6055G>C p.Ala2019Pro missense_variant Exon 46 of 47 ENSP00000507169.1 Q13936-35
CACNA1CENST00000682686.1 linkc.6031G>C p.Ala2011Pro missense_variant Exon 45 of 46 ENSP00000507309.1 Q13936-19

Frequencies

GnomAD3 genomes
AF:
0.0000329
AC:
5
AN:
152198
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000174
AC:
4
AN:
230536
AF XY:
0.0000158
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000292
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000131
AC:
19
AN:
1449246
Hom.:
1
Cov.:
33
AF XY:
0.0000111
AC XY:
8
AN XY:
719612
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33178
American (AMR)
AF:
0.0000228
AC:
1
AN:
43780
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25686
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39386
South Asian (SAS)
AF:
0.0000702
AC:
6
AN:
85426
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50928
Middle Eastern (MID)
AF:
0.000175
AC:
1
AN:
5712
European-Non Finnish (NFE)
AF:
0.00000633
AC:
7
AN:
1105388
Other (OTH)
AF:
0.0000669
AC:
4
AN:
59762
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000329
AC:
5
AN:
152198
Hom.:
0
Cov.:
33
AF XY:
0.0000134
AC XY:
1
AN XY:
74354
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41462
American (AMR)
AF:
0.000262
AC:
4
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4836
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68016
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.445
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000529
ExAC
AF:
0.00000831
AC:
1

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Timothy syndrome;C2678478:Brugada syndrome 3;CN260585:Long qt syndrome 8 Uncertain:1
Aug 11, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Uncertain:1
Mar 13, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.A2022P variant (also known as c.6064G>C), located in coding exon 46 of the CACNA1C gene, results from a G to C substitution at nucleotide position 6064. The alanine at codon 2022 is replaced by proline, an amino acid with highly similar properties. Based on data from gnomAD, the frequency for this variant is above the maximum credible frequency for a cardiac disease-causing variant in this gene based on internally established thresholds (Karczewski et al. Nature. 2020 May;581(7809):434-443; Whiffin et al. Genet Med. 2017 10;19:1151-1158). This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the supporting evidence, the association of this alteration with CACNA1C-related neurodevelopmental disorder is unknown; however, the association of this alteration with long QT syndrome or Timothy syndrome is unlikely. -

Long QT syndrome Benign:1
Oct 09, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
CardioboostArm
Benign
0.000013
BayesDel_addAF
Benign
-0.24
T
BayesDel_noAF
Benign
-0.47
CADD
Benign
19
DANN
Benign
0.97
DEOGEN2
Benign
0.012
T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;T;.;.;.;.;T;.;T
Eigen
Benign
-0.54
Eigen_PC
Benign
-0.42
FATHMM_MKL
Benign
0.35
N
M_CAP
Benign
0.075
D
MetaRNN
Benign
0.086
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
PhyloP100
0.42
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
-1.8
N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;.
REVEL
Benign
0.091
Sift
Benign
0.20
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;.
Sift4G
Benign
0.20
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
Polyphen
0.0, 0.0010, 0.0020, 0.0080, 0.0030
.;B;B;B;B;B;B;B;B;B;B;B;B;B;B;.;B;B;.;.;.;B;.
Vest4
0.21
MVP
0.28
MPC
0.25
ClinPred
0.070
T
GERP RS
4.3
gMVP
0.47
Mutation Taster
=83/17
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs758974396; hg19: chr12-2797892; API